AI technology developers Blackford and MedCognetics have established a commercial agreement to integrate MedCognetics’ CogNet AI-MT software into the Blackford Platform.
CogNet AI-MT is designed to enhance mammography cancer screening by supporting the detection of early tumors and enabling workflow prioritization, according to the vendors. Notably, the algorithm was trained on a diverse global patient data set to mitigate data biasing, Blackford said.
